Special Issues
Table of Content

Sarcoma Crossroads: Osteosarcoma, Bone Sarcoma, and Soft Tissue Sarcoma

Submission Deadline: 30 June 2025 (closed) View: 568 Submit to Journal

Guest Editors

Prof. Frank Traub

E-mail: Frank.Traub@unimedizin-mainz.de   

Affiliation: Department of Orthopaedics and Traumatology, University Medical Center of The Johannes Gutenberg University Mainz, D-55131 Mainz, Germany.

Homepage:   

Research Interests: Osteosarcoma, Sarcoma, Ewing's Sarcoma, Chondrosarcoma, Oncologic Orthopedia, Cancer, Cancer Biology

图片2.png


Summary

Sarcomas are rare and highly heterogeneous cancers, presenting significant challenges in diagnosis and treatment. Despite progress in individualized, multimodal approaches combining surgery, chemotherapy, and radiotherapy, more research is essential to refine these treatments and improve outcomes.

 

Diagnosis: Initial imaging and biopsy are critical, but more evidence is needed to enhance diagnostic accuracy and better differentiate between benign and malignant tumors. A deeper understanding of tumor subtypes and biological behaviors would aid in treatment planning.

 

Treatment Modalities: While limb-salvage surgery has replaced amputation for many soft tissue sarcomas, the optimal timing and necessity of radiotherapy—preoperative vs. postoperative—remain unclear. Further studies are needed, especially to determine whether radiotherapy can be safely omitted in low-risk cases.

 

Chemotherapy: The role of preoperative chemotherapy, particularly in conjunction with isolated limb perfusion, requires more evidence to establish its effectiveness in function preservation.

 

Retroperitoneal Sarcomas: Aggressive surgery is becoming standard, but additional research is critical to clarify the role of preoperative radiotherapy and chemotherapy in reducing the high risk of local recurrence.

 

Overall, a stronger evidence base is vital to advance sarcoma treatment, improve survival, and reduce recurrence rates. Continued research is crucial for optimizing treatment strategies and improving patient outcomes.


Keywords

Bone sarcoma, Soft tissue sarcoma, Sarcoma treatment, Multimodal therapy, Preoperative radiotherapy, Chemotherapy in sarcomas, Limb-salvage surgery, Retroperitoneal sarcoma treatment

Published Papers


  • Open Access

    ARTICLE

    An In Vitro Investigation of 5-Aminolevulinic Acid Mediated Photodynamic Therapy in Bone Sarcoma

    Rebecca H. Maggs, Marcus J. Brookes, Kenneth S. Rankin
    Oncology Research, DOI:10.32604/or.2025.069781
    (This article belongs to the Special Issue: Sarcoma Crossroads: Osteosarcoma, Bone Sarcoma, and Soft Tissue Sarcoma)
    Abstract Background: Photodynamic therapy (PDT) may eradicate residual malignant cells following sarcoma resection, through reactive oxygen species (ROS) mediated cytotoxicity, thus improve clinical outcomes. This study aims to assess the efficacy of 5-aminolevulinic acid (5-ALA) as a photosensitizer in combination with red light (RL) for PDT of bone sarcoma cells in vitro. Methods: Three bone sarcoma cell lines underwent treatment with 5-ALA and RL or sham-RL (SL). 5-ALA uptake was assessed using flow cytometry. Production of ROS was measured using CellROX Green staining and fluorescence microscopy. Cell viability was assessed using Cell Counting Kit-8 assays. Results: All cell… More >

Share Link